Member Exclusive

Qualification of academic facilities for small-scale automated manufacture of autologous cell-based products

Special Report by David Williams (EPSRC Center for Innovative Manufacturing in Regenerative Medicine, UK) where he and his team share their experiences in qualifying the Cell Therapy Manufacturing Facility, focusing on their approach to streamlining the qualification effort, the challenges, project delays and inefficiencies they encountered, and finally the subsequent lessons learned.

Go to the profile of Regenerative Medicine
Sep 15, 2016

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.